Evidence map›Paper›PMID 24796567›Full record

ArticleJournal of visualized experiments : JoVE2014

Demonstrating a multi-drug resistant Mycobacterium tuberculosis amplification microarray.

Yvonne Linger, Alexander Kukhtin, Julia Golova, Alexander Perov, Peter Qu, Christopher Knickerbocker, Christopher G Cooney, Darrell P Chandler

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yvonne LingerAkonni Biosystems, Inc.
Alexander KukhtinAkonni Biosystems, Inc.
Julia GolovaAkonni Biosystems, Inc.
Alexander PerovAkonni Biosystems, Inc.
Peter QuAkonni Biosystems, Inc.
Christopher KnickerbockerAkonni Biosystems, Inc.
Christopher G CooneyAkonni Biosystems, Inc.
Darrell P ChandlerAkonni Biosystems, Inc.; DChandler@akonni.com.

Funding

Diagnostic MDR- and XDR-TB PCR TruArrayRC3AI089106 · NIAID · AKONNI BIOSYSTEMS, INC. · PI CHANDLER, DARRELL P · 2010 to 2010
$3.0M
TB Diagnostics at the Point of CareR44EB011274 · NIBIB · AKONNI BIOSYSTEMS, INC. · PI COONEY, CHRISTOPHER GERARD · 2013 to 2015
$1.2M
NIAID NIH HHS RC3 AI089106NIBIB NIH HHS R44 EB011274
6 · The paper itself

Abstract

Simplifying microarray workflow is a necessary first step for creating MDR-TB microarray-based diagnostics that can be routinely used in lower-resource environments. An amplification microarray combines asymmetric PCR amplification, target size selection, target labeling, and microarray hybridization within a single solution and into a single microfluidic chamber. A batch processing method is demonstrated with a 9-plex asymmetric master mix and low-density gel element microarray for genotyping multi-drug resistant Mycobacterium tuberculosis (MDR-TB). The protocol described here can be completed in 6 hr and provide correct genotyping with at least 1,000 cell equivalents of genomic DNA. Incorporating on-chip wash steps is feasible, which will result in an entirely closed amplicon method and system. The extent of multiplexing with an amplification microarray is ultimately constrained by the number of primer pairs that can be combined into a single master mix and still achieve desired sensitivity and specificity performance metrics, rather than the number of probes that are immobilized on the array. Likewise, the total analysis time can be shortened or lengthened depending on the specific intended use, research question, and desired limits of detection. Nevertheless, the general approach significantly streamlines microarray workflow for the end user by reducing the number of manually intensive and time-consuming processing steps, and provides a simplified biochemical and microfluidic path for translating microarray-based diagnostics into routine clinical practice.

Indexed as

Drug Resistance, Multiple, BacterialMycobacterium tuberculosisPolymerase Chain ReactionTuberculosis

Identifiers

PMID24796567
PMCPMC4027031

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.